In contrast, there are few and inconclusive data about the significance of PD-L1 dysregulation during SARS-CoV-2 infection and no data are currently available on the role of soluble PD-L1 (sPD-L1) in COVID-19 patients with a different grade of disease severity and prognosis. The gene discussed is CD274; the disease is COVID-19.